Variant report
Variant | nsv547982 |
---|---|
Chromosome Location | chr1:158489945-158511445 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:210)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr1:158504406-158504592 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr1:158504293-158504614 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr1:158507626-158507887 | HepG2 | liver: | n/a | chr1:158507765-158507776 |
4 | CEBPB | chr1:158508750-158508969 | K562 | blood: | n/a | n/a |
5 | CTCF | chr1:158497094-158497299 | GM13977 | blood: | n/a | n/a |
6 | CTCF | chr1:158497100-158497250 | GM12873 | blood: | n/a | n/a |
7 | CTCF | chr1:158497085-158497280 | GM10248 | blood: | n/a | n/a |
8 | CTCF | chr1:158497220-158497370 | WI-38 | lung: | n/a | n/a |
9 | CTCF | chr1:158497044-158497281 | HepG2 | liver: | n/a | n/a |
10 | CTCF | chr1:158497120-158497270 | AoAF | blood vessel: | n/a | n/a |
11 | CTCF | chr1:158497120-158497270 | A549 | lung: | n/a | n/a |
12 | CTCF | chr1:158497080-158497230 | GM12873 | blood: | n/a | n/a |
13 | CTCF | chr1:158497076-158497303 | LNCaP | prostate: | n/a | n/a |
14 | CTCF | chr1:158497000-158497150 | HCT-116 | colon: | n/a | n/a |
15 | CTCF | chr1:158497080-158497230 | GM12801 | blood: | n/a | n/a |
16 | CTCF | chr1:158497120-158497270 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr1:158497001-158497362 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr1:158497081-158497323 | Kidney_OC | kidney: | n/a | n/a |
19 | CTCF | chr1:158497000-158497311 | SK-N-SH_RA | brain: | n/a | n/a |
20 | CTCF | chr1:158497030-158497368 | K562 | blood: | n/a | n/a |
21 | CTCF | chr1:158497100-158497250 | AG04450 | lung: | n/a | n/a |
22 | CTCF | chr1:158497120-158497270 | K562 | blood: | n/a | n/a |
23 | CTCF | chr1:158497098-158497201 | GM19238 | blood: | n/a | n/a |
24 | CTCF | chr1:158497140-158497290 | SAEC | small airway: | n/a | n/a |
25 | CTCF | chr1:158497100-158497250 | RPTEC | kidney: | n/a | n/a |
26 | CTCF | chr1:158497140-158497290 | Hela-S3 | cervix: | n/a | n/a |
27 | CTCF | chr1:158496854-158497575 | A549 | lung: | n/a | n/a |
28 | CTCF | chr1:158497120-158497270 | HPAF | blood vessel: | n/a | n/a |
29 | CTCF | chr1:158497180-158497330 | GM06990 | blood: | n/a | n/a |
30 | CTCF | chr1:158497065-158497317 | K562 | blood: | n/a | n/a |
31 | CTCF | chr1:158497080-158497230 | HFF-Myc | foreskin: | n/a | n/a |
32 | CTCF | chr1:158497120-158497270 | BE2_C | brain: | n/a | n/a |
33 | CTCF | chr1:158497120-158497270 | GM12866 | blood: | n/a | n/a |
34 | CTCF | chr1:158497100-158497250 | HVMF | connective: | n/a | n/a |
35 | CTCF | chr1:158497110-158497247 | SK-N-SH_RA | brain: | n/a | n/a |
36 | CTCF | chr1:158497100-158497250 | HPF | lung: | n/a | n/a |
37 | CTCF | chr1:158497100-158497250 | GM12870 | blood: | n/a | n/a |
38 | CTCF | chr1:158496983-158497264 | A549 | lung: | n/a | n/a |
39 | CTCF | chr1:158497140-158497290 | GM12874 | blood: | n/a | n/a |
40 | CTCF | chr1:158496992-158497277 | K562 | blood: | n/a | n/a |
41 | CTCF | chr1:158496960-158497354 | A549 | lung: | n/a | n/a |
42 | CTCF | chr1:158497120-158497270 | AG09319 | gingival: | n/a | n/a |
43 | CTCF | chr1:158497100-158497250 | AG09309 | skin: | n/a | n/a |
44 | CTCF | chr1:158497093-158497097 | GM19238 | blood: | n/a | n/a |
45 | CTCF | chr1:158497508-158497558 | GM10266 | blood: | n/a | n/a |
46 | CTCF | chr1:158496932-158497427 | MCF-7 | breast: | n/a | n/a |
47 | CTCF | chr1:158497120-158497270 | AG04449 | skin: | n/a | n/a |
48 | CTCF | chr1:158497067-158497285 | MCF-7 | breast: | n/a | n/a |
49 | CTCF | chr1:158497120-158497270 | AG04450 | lung: | n/a | n/a |
50 | CTCF | chr1:158497060-158497210 | HRE | kidney: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000231434 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180967288 | chr1:158490815-158490816 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547153467 | chr1:158490846-158490847 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs113669593 | chr1:158490865-158490866 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs549962066 | chr1:158490876-158490877 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186168475 | chr1:158490883-158490884 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532801562 | chr1:158490892-158490893 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143280358 | chr1:158490909-158490910 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569639535 | chr1:158490919-158490920 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113273299 | chr1:158490940-158490941 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183012306 | chr1:158491098-158491099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61560285 | chr1:158491203-158491204 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs77205466 | chr1:158491216-158491217 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs543369850 | chr1:158491246-158491247 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs553964237 | chr1:158491250-158491251 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs572461556 | chr1:158491376-158491377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187675948 | chr1:158491415-158491416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558155975 | chr1:158491427-158491428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576820546 | chr1:158491428-158491429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544110506 | chr1:158491429-158491430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1491193 | chr1:158491479-158491480 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs574146933 | chr1:158491480-158491481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541574771 | chr1:158491496-158491497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs950260 | chr1:158491520-158491521 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs12067180 | chr1:158491538-158491539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533020915 | chr1:158491562-158491563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550980271 | chr1:158491593-158491594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562929305 | chr1:158491601-158491602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542589433 | chr1:158491633-158491634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527286086 | chr1:158491641-158491642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530741658 | chr1:158491651-158491652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190952853 | chr1:158491653-158491654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567495206 | chr1:158491654-158491655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528282912 | chr1:158491669-158491670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546726992 | chr1:158491687-158491688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs59758212 | chr1:158491693-158491694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1491194 | chr1:158491699-158491700 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs536161821 | chr1:158491708-158491709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7416481 | chr1:158491719-158491720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369444423 | chr1:158491722-158491723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2317969 | chr1:158491753-158491754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs570041836 | chr1:158491791-158491792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551605516 | chr1:158491793-158491794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7518808 | chr1:158491820-158491821 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs574229277 | chr1:158491870-158491871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138976627 | chr1:158491871-158491872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553498614 | chr1:158491880-158491881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577699598 | chr1:158491953-158491954 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs530925085 | chr1:158492040-158492041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544684268 | chr1:158492041-158492042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562994484 | chr1:158492071-158492072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21045282 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:158490800-158491000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:158490800-158492000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr1:158491000-158491200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr1:158491000-158491600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr1:158491000-158491600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr1:158491000-158491800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr1:158491600-158491800 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr1:158491600-158492000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr1:158491800-158496800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr1:158491800-158497400 | Weak transcription | H1 Cell Line | embryonic stem cell |
11 | chr1:158492000-158497200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr1:158495800-158497400 | Enhancers | Dnd41 | blood |
13 | chr1:158496800-158498200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr1:158497000-158498000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr1:158497200-158497600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr1:158497200-158498000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr1:158497400-158497600 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr1:158497400-158498000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr1:158504200-158504800 | Enhancers | K562 | blood |
20 | chr1:158504200-158505000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
21 | chr1:158505400-158505600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
22 | chr1:158506600-158506800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
23 | chr1:158507400-158508200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr1:158507400-158508400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |